Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Twenty years on: the impact of fragments on drug discovery
Daniel A. Erlanson, Stephen W. Fesik, Roderick E. Hubbard, et al.
Nature Reviews Drug Discovery (2016) Vol. 15, Iss. 9, pp. 605-619
Closed Access | Times Cited: 871

Showing 1-25 of 871 citing articles:

Induced protein degradation: an emerging drug discovery paradigm
Ashton C. Lai, Craig M. Crews
Nature Reviews Drug Discovery (2016) Vol. 16, Iss. 2, pp. 101-114
Open Access | Times Cited: 1194
AKT as a Therapeutic Target for Cancer
Mengqiu Song, Ann M. Bode, Zigang Dong, et al.
Cancer Research (2019) Vol. 79, Iss. 6, pp. 1019-1031
Closed Access | Times Cited: 656
PROteolysis TArgeting Chimeras (PROTACs) — Past, present and future
Mariell Pettersson, Craig M. Crews
Drug Discovery Today Technologies (2019) Vol. 31, pp. 15-27
Open Access | Times Cited: 598
Expanding the medicinal chemistry synthetic toolbox
Jonas Boström, Dean G. Brown, Robert J. Young, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 10, pp. 709-727
Closed Access | Times Cited: 590
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
A. Douangamath, D. Fearon, Paul Gehrtz, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 486
A systematic analysis of atomic protein–ligand interactions in the PDB
Renato Ferreira de Freitas, Matthieu Schapira
MedChemComm (2017) Vol. 8, Iss. 10, pp. 1970-1981
Open Access | Times Cited: 460
Generative Recurrent Networks for De Novo Drug Design
Anvita Gupta, Alex T. Müller, Berend J. H. Huisman, et al.
Molecular Informatics (2017) Vol. 37, Iss. 1-2
Open Access | Times Cited: 392
Cryo-EM in drug discovery: achievements, limitations and prospects
Jean‐Paul Renaud, Ashwin Chari, Claudio Ciferri, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 7, pp. 471-492
Closed Access | Times Cited: 389
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies
Sean Caenepeel, Sean P. Brown, Brian Belmontes, et al.
Cancer Discovery (2018) Vol. 8, Iss. 12, pp. 1582-1597
Open Access | Times Cited: 373
Impact of a five-dimensional framework on R&D productivity at AstraZeneca
Paul Morgan, Dean G. Brown, Simon Lennard, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 3, pp. 167-181
Closed Access | Times Cited: 365
DNA-Encoded Chemical Libraries: A Selection System Based on Endowing Organic Compounds with Amplifiable Information
Dario Neri, Richard A. Lerner
Annual Review of Biochemistry (2018) Vol. 87, Iss. 1, pp. 479-502
Open Access | Times Cited: 327
Asymmetric organocatalysis: an enabling technology for medicinal chemistry
Bo Han, Xiang‐Hong He, Yanqing Liu, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 3, pp. 1522-1586
Closed Access | Times Cited: 319
Photocatalysis in the Life Science Industry
Lisa Candish, Karl D. Collins, Gemma C. Cook, et al.
Chemical Reviews (2021) Vol. 122, Iss. 2, pp. 2907-2980
Closed Access | Times Cited: 290
RNA Display Methods for the Discovery of Bioactive Macrocycles
Yichao Huang, Mareike M. Wiedmann, Hiroaki Suga
Chemical Reviews (2018) Vol. 119, Iss. 17, pp. 10360-10391
Closed Access | Times Cited: 230
Chemical probes and drug leads from advances in synthetic planning and methodology
Christopher J. Gerry, Stuart L. Schreiber
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 5, pp. 333-352
Open Access | Times Cited: 218
GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures
Ichio Shimada, Takumi Ueda, Yutaka Kofuku, et al.
Nature Reviews Drug Discovery (2018) Vol. 18, Iss. 1, pp. 59-82
Open Access | Times Cited: 218
Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders
Scott J. Hughes, Alessio Ciulli
Essays in Biochemistry (2017) Vol. 61, Iss. 5, pp. 505-516
Open Access | Times Cited: 213
Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)
Hang Zhang, Hai‐Wei Xu, Charles R. Ashby, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 1, pp. 525-555
Closed Access | Times Cited: 208
Theory and applications of differential scanning fluorimetry in early-stage drug discovery
Kai Gao, Rick Oerlemans, Matthew R. Groves
Biophysical Reviews (2020) Vol. 12, Iss. 1, pp. 85-104
Open Access | Times Cited: 200
In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
Lauro Ribeiro de Souza Neto, José Teófilo Moreira-Filho, Bruno J. Neves, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 200
DNA-Encoded Chemical Libraries: A Comprehensive Review with Succesful Stories and Future Challenges
Adrián Gironda-Martínez, Etienne J. Donckèle, Florent Samain, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 4, pp. 1265-1279
Open Access | Times Cited: 200
Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes
Emmanuelle Lautié, Olivier Russo, Pierre Ducrot, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 190
Heterobiaryl synthesis by contractive C–C coupling via P(V) intermediates
Michael C. Hilton, Xuan Zhang, Benjamin T. Boyle, et al.
Science (2018) Vol. 362, Iss. 6416, pp. 799-804
Open Access | Times Cited: 185
Principle and design of pseudo-natural products
George Karageorgis, Daniel J. Foley, Luca Laraia, et al.
Nature Chemistry (2020) Vol. 12, Iss. 3, pp. 227-235
Open Access | Times Cited: 184
Protein-protein interaction modulators: advances, successes and remaining challenges
Lloyd Mabonga, Abidemi Paul Kappo
Biophysical Reviews (2019) Vol. 11, Iss. 4, pp. 559-581
Open Access | Times Cited: 174
Page 1 - Next Page

Scroll to top